Long intergenic non-protein coding RNA 1700 (LINC01700)

Long intergenic non-protein coding RNA 1700 (LINC01700) is a long non-coding RNA gene that does not encode a protein and is classified as a long intergenic non-coding RNA (lincRNA)[1][3][7]. LINC01700 belongs to a large and heterogenous family of lincRNAs that are defined by their non-coding, intergenic genomic locations and transcript length greater than 200 nucleotides[5][7]. LincRNAs, including LINC01700, have been implicated in regulating gene expression at the transcriptional or post-transcriptional level, chromatin state modulation, and may exert enhancer-like effects, though most lincRNAs—including LINC01700—have not been characterized functionally in detail[5][7]. For LINC01700, no specific biological function or mechanism of action has yet been established; however, recent high-throughput and machine learning approaches have identified it as a potential biomarker for distinguishing tumor from normal tissues, especially in the context of lung cancer[2]. No drugs are currently known to interact with this RNA, and it is not recognized as a direct therapeutic target. There are no major safety concerns or therapeutic challenges reported for this lincRNA because it is not a drug target at present. The gene is referenced by various gene and transcript identifiers, such as NCBI Gene 101928435 and Ensembl ENSG00000232837[3]. No common alternative names exist beyond its standard gene symbol. Based on current knowledge, LINC01700 is best classified as a potential biomarker with unclear mechanistic roles in disease. Its biological significance remains to be elucidated in future functional studies.

Other names

LINC01700